News and Views For Neuropathy and Nerve Damage

Category: Journals

  • Relief from neuropathic pain with phenytoin cream according to new study

    Relief from neuropathic pain with phenytoin cream according to new study

    Phenytoin provided temporary relief from neuropathic pain reports a recent study in the Journal of Pain Research. The doctors, Jan M. Keppel Hesselink and David Kopsky, from the Institute for Neuropathic Pain in Amsterdam, summarized their findings on the benefits of a 10% topical cream with phenytoin as the active ingredient as follows. “We, therefore, developed a…

  • What can be done for elderly patients with peripheral neuropathy to prevent serious injury from falls?

    Elderly people with type-2 diabetes mellitus(T2DM) and diabetic peripheral neuropathy (DPN) may be more prone to suffer severe injuries due to tripping and falling. A startling statistic reveals an older adults are admitted to hospitals every 13 seconds, on average, due to falls, while one death results from a fall every 20 minutes. A recent…

  • Toxic Neuropathy Drugs

    “There is a daunting list of toxins that can affect the peripheral nervous system,” according to a study published by Dr. Hani Kusiaf of the Department of Neurology at the Mayo Clinic in Minnesota. A host of potentially toxic neuropathy and myopathy drugs are unintentionally being released from research laboratories around the world, because the…

  • Alemtuzumab Approved For Multiple Sclerosis

    ,

    The FDA has approved alemtuzumab (Lemtrada) as a treatment for patients with multiple sclerosis. The FDA was careful to cite that use of alemtuzumab was a high-risk option since the drug may cause an increased risk for malignancies, including thyroid cancer, melanoma, lymphoproliferative disorders, neuropathy, which in some instances proved fatal. The medication is also marketed as Campath, which…